Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

An open trial of valproate in borderline personality disorder.

Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.

J Clin Psychiatry. 1995 Nov;56(11):506-10.

PMID:
7592502
2.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
3.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
4.

Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.

Kavoussi RJ, Coccaro EF.

J Clin Psychiatry. 1998 Dec;59(12):676-80.

PMID:
9921702
5.

An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.

Simeon D, Baker B, Chaplin W, Braun A, Hollander E.

CNS Spectr. 2007 Jun;12(6):439-43.

PMID:
17545954
6.
8.

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.

J Clin Psychiatry. 1999 Sep;60(9):598-603.

PMID:
10520978
9.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
10.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151
11.

[Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].

Chabrol H, Chouicha K, Montovany A, Callahan S.

Encephale. 2001 Mar-Apr;27(2):120-7. French.

PMID:
11407263
12.

Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.

J Clin Psychopharmacol. 2008 Apr;28(2):147-55. doi: 10.1097/JCP.0b013e318166c4bf.

PMID:
18344724
13.

Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety.

Comtois KA, Cowley DS, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1999 Nov;60(11):752-8.

PMID:
10584763
14.

Treatment of borderline personality disorder with risperidone.

Rocca P, Marchiaro L, Cocuzza E, Bogetto F.

J Clin Psychiatry. 2002 Mar;63(3):241-4.

PMID:
11926724
15.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
16.

Yi-gan san for the treatment of borderline personality disorder: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. Epub 2007 Aug 8.

PMID:
17765378
17.

Panic disorder: treatment with valproate.

Woodman CL, Noyes R Jr.

J Clin Psychiatry. 1994 Apr;55(4):134-6.

PMID:
8071256
18.

Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2005 Sep;66(9):1111-5.

PMID:
16187767
19.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
20.

Fluoxetine in the treatment of anger: an open clinical trial.

Rubey RN, Johnson MR, Emmanuel N, Lydiard RB.

J Clin Psychiatry. 1996 Sep;57(9):398-401.

PMID:
9746447

Supplemental Content

Support Center